Novartis has reported positive efficacy and safety outcomes from its Phase III clinical programme for OAV101 IT (onasemnogene ...

This FAQ will look at the advantages and attributes of three-phase AC, also called multiphase or polyphase AC.

Novartis (NVS) announced positive safety and efficacy results from the Phase III program for investigational intrathecal onasemnogene ...

Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the ...

Electric motors are critical assets in many applications, so access to nameplate ratings and terminal markings can save time ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.

Modern digital multimeters (DMMs) are user-friendly, accurate, and safe — when used correctly! Reading voltage is simple, but ...

Dispatches for Honda's latest electric scooters, Activa e: and QC1, have commenced. Read the story to find out how much you ...

Scholar Rock’s spinal muscular atrophy (SMA) therapy has shown benefit in muscle function in children under 12 in a pivotal ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

The California Public Utilities Commission has granted Tesla the first in a series of approvals from California to operate ...